0161 731 0056

New Leglisation Adreniline Injectors in Schools


7th July 2017

New legislation was passed in Westminster this week to allow schools in the UK to keep spare adrenaline auto-injectors (AAIs) for emergency use. AAIs deliver a potentially life-saving dose of adrenaline in the event of a severe allergic reaction (anaphylaxis).

The legislation comes into effect from 1 October 2017.

A working group, made up of representatives from the Anaphylaxis Campaign, Allergy UK, the British Society for Allergy & Clinical Immunology (BSACI), the British Paediatric Allergy Immunity and Infection Group (BPAIIG), and the Royal College of Paediatrics and Child Health (RCPCH), has strongly campaigned over the last two years for the Government to amend the Human Medicines Act to allow schools to buy AAIs from a pharmaceutical supplier, without prescription, for use in emergencies.

The above working group and their respective organisations have welcomed the new legislation which allows school staff to administer an emergency AAI to any child who has been assessed as being at risk of anaphylaxis.
Their campaign gained a huge groundswell of support from parents and teachers: over 1600 parents/carers and 800 teachers completed a survey in 2015 to assess backing for the campaign: over 99% of parents and 96% of teachers supported the proposal.

This survey formed a crucial part of the evidence presented to the Department of Health. A public consultation conducted by the Department of Health this year also found overwhelming support for a change in the law to allow schools to hold spare AAIs, without a prescription, for use in emergencies.

The following joint statement on the 7th July 2017 from the above five organisations states:
“The rise in food allergy among young people is posing a significant risk for schools who can be faced with a life-threatening situation requiring urgent action. One in five fatal food-allergic reactions in children happen at school. Schools can now purchase the first-line treatment for anaphylaxis, without a prescription. While not compulsory, we hope many schools will take advantage of this change as part of their duty of care to those children who are at risk of anaphylaxis. This is likely to increase awareness and highlight the need for staff to be trained to recognise and treat anaphylaxis in school. The working group is now developing a website which will provide online resources to support school staff.
For a parent of a child at risk from anaphylaxis, this will provide valuable reassurance that their child can receive prompt emergency treatment while on school premises.
We are delighted that our campaign has delivered the result we hoped for.”

Remote First Aid delivers fully compliant stand-alone regulated qualification in Basic Life Support & Management of Anaphylaxis or if you wish we can incorporate this training in to either the Emergency aid or First aid at work courses within their respective basic life support sections for a small additional certification fee per delegate.


Principal or Head Teacher? 1st October 2017….

From this date onwards, schools can buy AAIs, without a prescription, for use in emergencies from a pharmaceutical supplier in small quantities provided it is done on an occasional basis and is not for profit.

A supplier will need a request signed by the principal or head teacher (ideally on appropriately headed paper) stating:
the name of the school for which the product is required; 

  • the purpose for which that product is required, and 
  • the total quantity required.

The Department of Health is also producing non-statutory guidance to support schools in England in their management of AAIs.

As Devolved Administrations, Wales, Northern Ireland and Scotland will have respective responsibility for issuing their own guidance to their schools.

Leave a Reply Text

Your email address will not be published. Required fields are marked *